Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2014, 15(4), 5762-5773; doi:10.3390/ijms15045762
Article

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma

1,2,* , 1
, 3
, 4
, 4
, 5
, 6
, 7
, 7
, 8
, 6
, 5
, 4
, 3
, 2
 and 1
Received: 27 February 2014; in revised form: 17 March 2014 / Accepted: 21 March 2014 / Published: 4 April 2014
(This article belongs to the collection Molecular Mechanisms of Human Liver Diseases)
View Full-Text   |   Download PDF [4528 KB, uploaded 19 June 2014]
Abstract: Non-alcoholic steatohepatitis (NASH) represents a risk factor for the development of hepatocellular carcinoma (HCC) and is characterized by quantitative and qualitative changes in hepatic lipids. Since elongation of fatty acids from C16 to C18 has recently been reported to promote both hepatic lipid accumulation and inflammation we aimed to investigate whether a frequently used mouse NASH model reflects this clinically relevant feature and whether C16 to C18 elongation can be observed in HCC development. Feeding mice a methionine and choline deficient diet to model NASH not only increased total hepatic fatty acids and cholesterol, but also distinctly elevated the C18/C16 ratio, which was not changed in a model of simple steatosis (ob/ob mice). Depletion of Kupffer cells abrogated both quantitative and qualitative methionine-and-choline deficient (MCD)-induced alterations in hepatic lipids. Interestingly, mimicking inflammatory events in early hepatocarcinogenesis by diethylnitrosamine-induced carcinogenesis (48 h) increased hepatic lipids and the C18/C16 ratio. Analyses of human liver samples from patients with NASH or NASH-related HCC showed an elevated expression of the elongase ELOVL6, which is responsible for the elongation of C16 fatty acids. Taken together, our findings suggest a detrimental role of an altered fatty acid pattern in the progression of NASH-related liver disease.
Keywords: diethylnitrosamine; ELOVL6; HCC; hepatic steatosis; leptin deficiency; MCD; non-alcoholic fatty liver disease (NAFLD); ob/ob diethylnitrosamine; ELOVL6; HCC; hepatic steatosis; leptin deficiency; MCD; non-alcoholic fatty liver disease (NAFLD); ob/ob
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Kessler, S.M.; Simon, Y.; Gemperlein, K.; Gianmoena, K.; Cadenas, C.; Zimmer, V.; Pokorny, J.; Barghash, A.; Helms, V.; van Rooijen, N.; Bohle, R.M.; Lammert, F.; Hengstler, J.G.; Mueller, R.; Haybaeck, J.; Kiemer, A.K. Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Int. J. Mol. Sci. 2014, 15, 5762-5773.

AMA Style

Kessler SM, Simon Y, Gemperlein K, Gianmoena K, Cadenas C, Zimmer V, Pokorny J, Barghash A, Helms V, van Rooijen N, Bohle RM, Lammert F, Hengstler JG, Mueller R, Haybaeck J, Kiemer AK. Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2014; 15(4):5762-5773.

Chicago/Turabian Style

Kessler, Sonja M.; Simon, Yvette; Gemperlein, Katja; Gianmoena, Kathrin; Cadenas, Cristina; Zimmer, Vincent; Pokorny, Juliane; Barghash, Ahmad; Helms, Volkhard; van Rooijen, Nico; Bohle, Rainer M.; Lammert, Frank; Hengstler, Jan G.; Mueller, Rolf; Haybaeck, Johannes; Kiemer, Alexandra K. 2014. "Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma." Int. J. Mol. Sci. 15, no. 4: 5762-5773.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert